TW201702243A - 用於治療發炎病症之新穎二氫吡啶異喹啉酮及其醫藥組合物 - Google Patents

用於治療發炎病症之新穎二氫吡啶異喹啉酮及其醫藥組合物 Download PDF

Info

Publication number
TW201702243A
TW201702243A TW105112490A TW105112490A TW201702243A TW 201702243 A TW201702243 A TW 201702243A TW 105112490 A TW105112490 A TW 105112490A TW 105112490 A TW105112490 A TW 105112490A TW 201702243 A TW201702243 A TW 201702243A
Authority
TW
Taiwan
Prior art keywords
compound
independently selected
pharmaceutically acceptable
acceptable salt
methyl
Prior art date
Application number
TW105112490A
Other languages
English (en)
Chinese (zh)
Inventor
克里斯托 奇尼 馬瑞 米那
朱利安 喬治斯 皮亞爾 奧利維亞 道央
彼德 伊莎貝爾 羅傑 克拉耶
布理吉特 阿拉赫
瓦徹 瑪辛 瑪利亞 保羅 德
裘瓦尼 亞歷山卓 翠卡理寇
Original Assignee
葛萊伯格有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 葛萊伯格有限公司 filed Critical 葛萊伯格有限公司
Publication of TW201702243A publication Critical patent/TW201702243A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW105112490A 2015-04-23 2016-04-21 用於治療發炎病症之新穎二氫吡啶異喹啉酮及其醫藥組合物 TW201702243A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1506894.3A GB201506894D0 (en) 2015-04-23 2015-04-23 Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
TW201702243A true TW201702243A (zh) 2017-01-16

Family

ID=53488521

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105112490A TW201702243A (zh) 2015-04-23 2016-04-21 用於治療發炎病症之新穎二氫吡啶異喹啉酮及其醫藥組合物

Country Status (19)

Country Link
US (1) US10568879B2 (cg-RX-API-DMAC7.html)
EP (1) EP3286191B1 (cg-RX-API-DMAC7.html)
JP (1) JP6777652B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170139142A (cg-RX-API-DMAC7.html)
CN (1) CN107531703B (cg-RX-API-DMAC7.html)
AR (1) AR104362A1 (cg-RX-API-DMAC7.html)
AU (1) AU2016251517A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017022008A2 (cg-RX-API-DMAC7.html)
CA (1) CA2983342A1 (cg-RX-API-DMAC7.html)
CO (1) CO2017011093A2 (cg-RX-API-DMAC7.html)
GB (1) GB201506894D0 (cg-RX-API-DMAC7.html)
IL (1) IL255109A0 (cg-RX-API-DMAC7.html)
MX (1) MX2017013382A (cg-RX-API-DMAC7.html)
PH (1) PH12017501911A1 (cg-RX-API-DMAC7.html)
RU (1) RU2017134551A (cg-RX-API-DMAC7.html)
SG (1) SG11201708671RA (cg-RX-API-DMAC7.html)
TW (1) TW201702243A (cg-RX-API-DMAC7.html)
WO (1) WO2016169911A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201706674B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3403649A1 (en) * 2017-05-16 2018-11-21 Bayer Pharma Aktiengesellschaft Inhibitors and antagonists of gpr84 for the treatment of endometriosis
CN106977483A (zh) * 2017-06-02 2017-07-25 遵义医学院 一种二氟烷基取代的黄酮醇、异黄酮醇和香豆素类化合物的合成方法
IL301709B2 (en) 2017-08-09 2025-07-01 Denali Therapeutics Inc Compounds, compositions and methods
TW201920129A (zh) 2017-09-01 2019-06-01 美商戴納立製藥公司 化合物、組合物及方法
US20210106582A1 (en) 2017-11-15 2021-04-15 Galapagos Nv Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
WO2020007342A1 (zh) * 2018-07-06 2020-01-09 中国科学院上海药物研究所 联苯磷酸酯类化合物作为gpr84拮抗剂的应用
EP3924341A4 (en) 2019-02-13 2022-11-02 Denali Therapeutics Inc. Compounds, compositions and methods
CR20210426A (es) * 2019-02-13 2021-09-30 Denali Therapeutics Inc Compuestos, composiciones y métodos
PH12022551509A1 (en) * 2019-12-19 2023-04-24 Bayer Ag Furoindazole derivatives
WO2021123394A1 (en) 2019-12-20 2021-06-24 University Of Copenhagen G protein-coupled receptor modulators and a pharmaceutical composition
TW202241857A (zh) 2020-12-18 2022-11-01 美商戴納立製藥公司 化合物之固體形式
KR20230153387A (ko) 2021-02-02 2023-11-06 리미널 바이오사이언시스 리미티드 Gpr84 길항제 및 이의 용도
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Gpr84アンタゴニストおよびその使用
WO2022179940A1 (en) 2021-02-23 2022-09-01 Bayer Aktiengesellschaft Furoindazole derivatives as gpr84 antagonists
WO2022218372A1 (zh) * 2021-04-14 2022-10-20 武汉人福创新药物研发中心有限公司 一种二氢嘧啶并异喹啉酮类衍生物及用途
WO2022229061A1 (en) 2021-04-29 2022-11-03 Bayer Aktiengesellschaft Furoindazole derivatives as antagonists or inhibitors of gpr84
WO2022263676A1 (en) 2021-06-18 2022-12-22 University Of Copenhagen Polysubstituted 4-hydroxypyridine and 4-hydroxyquinoline derivatives as gpr84 antagonists
CN115611944A (zh) 2021-07-15 2023-01-17 中国科学院上海药物研究所 不对称gpr84拮抗剂及其用途
WO2024083705A1 (en) 2022-10-18 2024-04-25 Bayer Aktiengesellschaft Furoindazole derivatives for the treatment of pain
USD1117011S1 (en) * 2024-07-10 2026-03-10 Delta Electronics, Inc. Charging connector
USD1119767S1 (en) * 2024-07-10 2026-03-24 Delta Electronics, Inc. Charging connector

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0926148A1 (en) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors
WO2005050225A2 (en) * 2003-10-31 2005-06-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 84 (gpr84)
CA2621144A1 (en) 2005-09-02 2007-03-08 Arena Pharmaceuticals, Inc. Human g protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to mcp-1 expression
EP2619203A4 (en) 2010-09-20 2014-04-16 Glaxo Group Ltd TRICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND APPLICATIONS THEREOF
AR089284A1 (es) * 2011-12-22 2014-08-13 Galapagos Nv Dihidropirimidinoisoquinolinonas y composiciones farmaceuticas de las mismas para el tratamiento de trastornos inflamatorios
JP6293784B2 (ja) 2012-12-20 2018-03-14 ガラパゴス・ナムローゼ・フェンノートシャップGalapagos N.V. 炎症性障害の治療のための新規ジヒドロピリミジノイソキノリノン及びその医薬組成物(gpr84アンタゴニスト)
GB201411241D0 (en) 2014-06-25 2014-08-06 Galapagos Nv Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Also Published As

Publication number Publication date
JP2018513180A (ja) 2018-05-24
AU2016251517A1 (en) 2017-10-26
RU2017134551A (ru) 2019-04-04
US20190062325A1 (en) 2019-02-28
US10568879B2 (en) 2020-02-25
EP3286191B1 (en) 2020-07-29
CN107531703A (zh) 2018-01-02
CN107531703B (zh) 2020-09-01
KR20170139142A (ko) 2017-12-18
CO2017011093A2 (es) 2018-01-31
WO2016169911A1 (en) 2016-10-27
IL255109A0 (en) 2017-12-31
MX2017013382A (es) 2017-12-07
PH12017501911A1 (en) 2018-03-05
GB201506894D0 (en) 2015-06-10
AR104362A1 (es) 2017-07-12
EP3286191A1 (en) 2018-02-28
BR112017022008A2 (pt) 2018-07-03
CA2983342A1 (en) 2016-10-27
ZA201706674B (en) 2019-07-31
JP6777652B2 (ja) 2020-10-28
SG11201708671RA (en) 2017-11-29

Similar Documents

Publication Publication Date Title
CN107531703B (zh) 用于治疗炎症性疾病的二氢吡啶并异喹啉酮类及其药物组合物
JP6775645B2 (ja) Pimキナーゼ阻害剤として有用なチアゾールカルボキサミドおよびピリジンカルボキサミド化合物
EP3692040B1 (en) Chemical compounds
ES2905755T3 (es) Derivados de piperidina
TWI567073B (zh) 用於治療發炎疾病之新穎二氫嘧啶異喹啉酮及醫藥組成物
JP6293784B2 (ja) 炎症性障害の治療のための新規ジヒドロピリミジノイソキノリノン及びその医薬組成物(gpr84アンタゴニスト)
EP2943485B1 (en) Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
JP2022526926A (ja) イミダゾロニルキノリン化合物およびそれらの治療への使用
JP2016528298A (ja) Pimキナーゼ阻害剤として有用なフロピリジン及びチエノピリジンカルボキシアミド化合物
CN118359612A (zh) 用于治疗疾病的化合物及其药物组合物
TW201623285A (zh) 新穎雜芳基化合物及其作為藥物之用途
WO2015197550A1 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
JP2014507414A (ja) 代謝疾患及び炎症疾患の治療に有用なアゼチジン誘導体
BR112019001551B1 (pt) Moduladores do receptor de piperidina cxcr7, seu uso e composição farmacêutica os compreendendo
HK40006072A (en) Piperidine cxcr7 receptor modulators
HK1216316B (en) Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors